Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis

Abstract

Plasmin is essential for metalloproteases activation, endothelial cell migration and degradation of the extracellular matrix. The process is common to neoangiogenesis pannus formation and cartilage degradation within arthritic joints. Since 80% of synovial cells express urokinase plasminogen activator receptor (uPAR), we investigated the inhibition of plasmin activation in a collagen-induced arthritis (CIA) mice model, by expressing a uPA/uPAR antagonist molecule (ATF) fused to human serum albumin (HSA) to extend its serum half-life. Overexpression was obtained with an adenoviral vector expressing the chimeric murine ATF-HSA. We showed that the genetic coupling did not significantly reduce the ability of the ATF moiety to interact with its receptor uPAR. The chimeric protein was detectable in the sera of injected mice 7 days following Ad-mATF-HSA injection, then decreased in parallel with the anti-HSA titer increase. Systemic Ad-mATF-HSA injection performed on day 25 following CIA induction decreased the incidence of arthritis and the severity of the disease. Moreover, synovial angiogenesis in arthritic paws was decreased after Ad-mATF-HSA gene transfer, as assessed by smooth muscle actin immunostaining. The preventive effect observed on arthritis was related to the decrease in angiogenesis, rather than inhibition of extracellular matrix degradation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Koch A.E. . Review: angiogenesis: implications for rheumatoid arthritis Arthritis Rheum 1998 41: 951 951

    Article  CAS  Google Scholar 

  2. Firestein G.S. . Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis J Clin Invest 1999 103: 3 3

    Article  CAS  Google Scholar 

  3. Zhang Y. et al. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1 Proc Natl Acad Sci USA 2000 97: 6427 6427

    Article  CAS  Google Scholar 

  4. Nagashima M. et al. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis Rheumatology (Oxford) 2000 39: 1255 1255

    Article  CAS  Google Scholar 

  5. Nagashima M., Asano G., Yoshino S. . Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis J Rheumatol 2000 27: 2339 2339

    CAS  PubMed  Google Scholar 

  6. Storgard C.M. et al. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist J Clin Invest 1999 103: 47 47

    Article  CAS  Google Scholar 

  7. Peacock D.J., Banquerigo M.L., Brahn E. . Angiogenesis inhibition suppresses collagen arthritis J Exp Med 1992 175: 1135 1135

    Article  CAS  Google Scholar 

  8. Oliver S.J. et al. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF) Cell Immunol 1995 166: 196 196

    Article  CAS  Google Scholar 

  9. Lu J. et al. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis J Immunol 2000 164: 5922 5922

    Article  CAS  Google Scholar 

  10. Szekanecz Z., Haines G.K., Koch A.E. . Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues J Clin Pathol 1997 50: 314 314

    Article  CAS  Google Scholar 

  11. Pollanen J., Stephens R.W., Vaheri A. . Directed plasminogen activation at the surface of normal and malignant cells Adv Cancer Res 1991 57: 273 273

    Article  CAS  Google Scholar 

  12. Pepper M.S. et al. Upregulation of urokinase receptor expression on migrating endothelial cells J Cell Biol 1993 122: 673 673

    Article  CAS  Google Scholar 

  13. Busso N. . Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints Ann Rheum Dis 1997 56: 550 550

    Article  CAS  Google Scholar 

  14. Kobayashi H. et al. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro J Biol Chem 1995 270: 8361 8361

    Article  CAS  Google Scholar 

  15. Li H. et al. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice Gene Therapy 1998 5: 1105 1105

    Article  CAS  Google Scholar 

  16. Li H. et al. Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice Hum Gene Ther 1999 10: 3045 3045

    Article  CAS  Google Scholar 

  17. Min H.Y. et al. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice Cancer Res 1996 56: 2428 2428

    CAS  Google Scholar 

  18. Walsh D.A. . Angiogenesis and arthritis Rheumatology (Oxford) 1999 38: 103 103

    Article  CAS  Google Scholar 

  19. Ronday H.K. et al. Tranexamic acid, an inhibitor of plasminogen activation, reduces urinary collagen cross-link excretion in both experimental and rheumatoid arthritis Br J Rheumatol 1998 37: 34 34

    Article  CAS  Google Scholar 

  20. Van der Land W.H. et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor Arthritis Rheum 2000 43: 1710 1710

    Article  Google Scholar 

  21. Stehle G. et al. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate Anticancer Drugs 1999 10: 785 785

    Article  CAS  Google Scholar 

  22. Carter D.C., Ho J.X. . Structure of serum albumin Adv Protein Chem 1994 45: 153 153

    Article  CAS  Google Scholar 

  23. Yeh P. et al. Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate Proc Natl Acad Sci USA 1992 89: 1904 1904

    Article  CAS  Google Scholar 

  24. Worgall S. et al. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum Gene Ther 1997 8: 37 37

    Article  CAS  Google Scholar 

  25. Crouzet J. et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes Proc Natl Acad Sci USA 1997 94: 1414 1414

    Article  CAS  Google Scholar 

  26. Joosten L.A. et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation J Immunol 1999 163: 5049 5049

    CAS  PubMed  Google Scholar 

  27. Apparailly F. et al. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis J Immunol 1998 160: 5213 5213

    CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Michèle Radal from the CRLC Val d'Aurelle in Montpellier for the preparation of histology sections, and the breast radiography group from Lapeyronie Hospital in Montpellier who performed the X-rays. We also acknowledge Elisabeth Connault from UMR1582/CNRS-IGR for performing immunohistogical technical support.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Apparailly, F., Bouquet, C., Millet, V. et al. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis. Gene Ther 9, 192–200 (2002). https://doi.org/10.1038/sj.gt.3301628

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301628

Keywords

This article is cited by

Search

Quick links